Custom Premix Selecting "Custom Premix" option means that all of the beads you have chosen will be premixed in manufacturing before the kit is sent to you.
Catalogue Number
Ordering Description
Qty/Pack
List
この品目はお気に入りに追加されました。
動物種
パネルタイプ
選択したキット
数量
カタログ番号
注文内容
Qty/Pk
価格
96-Well Plate
数量
カタログ番号
注文内容
Qty/Pk
価格
その他の試薬を追加 (MAPmatesとともに使用するにはバッファーおよび検出キットが必要です)
数量
カタログ番号
注文内容
Qty/Pk
価格
48-602MAG
Buffer Detection Kit for Magnetic Beads
1 Kit
Space Saver Option(チェックを入れると箱詰めから袋詰めに変更となりますのでご注意ください) Customers purchasing multiple kits may choose to save storage space by eliminating the kit packaging and receiving their multiplex assay components in plastic bags for more compact storage.
Understanding the health risk that exposure to environmental or administered agents pose to human health is of central importance to the field of Toxicology. The micronucleus assay is commonly employed to assess the genotoxic potential of compounds or drug candidates - those that pose a threat induce the formation of chromosome fragments that are not pulled toward the daughter cells during cell division. Such micronuclei are counted using manual microscopy techniques. The combination of high speed image acquisition and quantitative image analysis provided by Amnis® imaging flow cytometry system is a major improvement to this field of study, enabling rapid automated identification of micronuclei-containing cells.
The micronucleus assay is the preferred method for evaluating the genotoxicity of drugs and other chemical agents. This experiment demonstrates the ability of the Imagestream®x system to rapidly classify apoptotic, bi-nucleated, and micronucleated events within cell populations simply using brightfield and nuclear imagery. Traditionally, cell biologists performing micronucleus assays have had to choose between manual microscopy, which is time-consuming and tedious, and flow cytometry, which can rapidly process large cell populations but lacks the ability to image the nucleus in intact cells. The Amnis® Imagestream®x system solves both problems by combining flow cytometry with sophisticated digital imaging and analysis capabilities.